Lv1
44 积分 2025-07-17 加入
Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort study
7天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已完结
T-cell engagers in rheumatology
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
1个月前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review
1个月前
已完结
Infectious complications following CAR-t cell therapy for B cell non-Hodgkin lymphoma: a single-center experience and review of the literature
1个月前
已完结
皖公网安备34019202002308
